Published in Clin Exp Immunol on February 01, 2005
Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell (2007) 8.42
IL-10-dependent partial refractoriness to Toll-like receptor stimulation modulates gut mucosal dendritic cell function. Eur J Immunol (2008) 1.97
Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin Vaccine Immunol (2006) 1.47
Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants. J Clin Invest (2008) 1.38
Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol (2007) 1.34
Interleukin-4 can induce interleukin-4 production in dendritic cells. Immunology (2006) 0.91
IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response. J Immunol (2009) 0.89
Cytokine-Induced Modulation of Colorectal Cancer. Front Oncol (2016) 0.84
Tolerogenic interactions between CD8+ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts. Blood (2017) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 22.57
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol (2001) 11.07
An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med (1999) 10.67
Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology (1998) 9.58
Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (2004) 8.68
Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature (2003) 7.56
A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science (2000) 5.78
Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science (2000) 5.38
Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med (1996) 5.32
Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol (2001) 5.11
The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med (1992) 4.58
The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med (2002) 3.91
Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med (1999) 3.79
Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med (2003) 3.74
Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest (2003) 3.73
Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med (2000) 2.99
Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J Immunol (2001) 2.93
Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol (1997) 2.89
Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med (1998) 2.85
T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med (1996) 2.79
Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J Exp Med (1993) 2.55
Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol (2002) 2.45
Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol (1998) 2.01
Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J Immunol (1995) 1.88
Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity (1999) 1.72
Migration and maturation of human colonic dendritic cells. J Immunol (2001) 1.64
Dendritic cells, the major antigen-presenting cells of the human colonic lamina propria. Immunology (1993) 1.29
Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur J Immunol (1997) 1.27
DEC-205 as a marker of dendritic cells with regulatory effects on CD8 T cell responses. Int Immunol (2000) 1.09
Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis. Eur J Immunol (2003) 1.09
Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur J Immunol (1999) 1.05
Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Leukemia (2003) 1.04
A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells. J Immunol (2000) 1.01
Visualizing the T-cell response elicited by oral administration of soluble protein antigen. Immunology (1999) 1.00
Distribution of human colonic dendritic cells and macrophages. Clin Exp Immunol (1996) 0.99
The regulation of T cell responses by a subpopulation of CD8+DEC205+ murine dendritic cells. Adv Exp Med Biol (1997) 0.82
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol (2001) 7.43
Persistent pain and faecal urgency after stapled haemorrhoidectomy. Lancet (2000) 7.09
Anal-sphincter disruption during vaginal delivery. N Engl J Med (1993) 5.74
Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med (1987) 5.14
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80
Prospective comparison of faecal incontinence grading systems. Gut (1999) 3.48
Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology (1986) 3.25
Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med (1989) 3.16
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut (2004) 3.01
Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair. BMJ (1994) 2.75
Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology (1986) 2.72
Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood (1990) 2.68
Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A (1983) 2.68
Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology (1990) 2.58
Role of veiled cells in lymphocyte activation. Eur J Immunol (1982) 2.50
The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen. Cell Immunol (1985) 2.43
Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J Gen Virol (1987) 2.38
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet (1997) 2.38
Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut (2004) 2.29
Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut (2009) 2.20
AGA technical review on anorectal testing techniques. Gastroenterology (1999) 2.05
Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet (1994) 2.04
A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine (1995) 2.03
Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol (1999) 2.01
Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut (1993) 2.01
Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol (1993) 2.00
Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil (2011) 1.99
Veiled cells--"dendritic cells" of the peripheral lymph. Immunobiology (1984) 1.86
Systematic review of sacral nerve stimulation for faecal incontinence and constipation. Br J Surg (2004) 1.84
The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut (2003) 1.84
Long-term clinical outcome of surgery for solitary rectal ulcer syndrome. Br J Surg (1998) 1.80
Pilot study of two new injectable bulking agents for the treatment of faecal incontinence. Colorectal Dis (2007) 1.78
Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis (2009) 1.75
Permanent sacral nerve stimulation for treatment of idiopathic constipation. Br J Surg (2002) 1.75
Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut (2001) 1.75
Bowel dysfunction in spinal-cord-injury patients. Lancet (1996) 1.74
Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther (2003) 1.73
Long-term results of overlapping anterior anal-sphincter repair for obstetric trauma. Lancet (2000) 1.72
Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut (1997) 1.71
Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut (1993) 1.71
A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine (1997) 1.70
Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. Lancet (2000) 1.69
Haemorrhoids: pathology, pathophysiology and aetiology. Br J Surg (1994) 1.67
Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture. J Immunol Methods (1980) 1.66
Migration and maturation of human colonic dendritic cells. J Immunol (2001) 1.64
The burden of constipation on quality of life: results of a multinational survey. Aliment Pharmacol Ther (2007) 1.64
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut (2004) 1.63
The role of dendritic cells in the initiation of immune responses to contact sensitizers. II. Studies in nude mice. Cell Immunol (1985) 1.62
Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg (2000) 1.61
Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol (1994) 1.61
Suppression of immune responses by dendritic cells infected with HIV. Immunology (1989) 1.61
Exceptional lymphocyte stimulating capacity of cells from lymphoid cell lines. Nature (1969) 1.60
Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother (1998) 1.60
Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut (1996) 1.60
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology (2001) 1.57
'Reversible chemical sphincterotomy' by local application of glyceryl trinitrate. Br J Surg (1994) 1.55
Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum (1974) 1.52
Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut (2005) 1.49
A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther (2008) 1.49
Solitary rectal ulcer syndrome. Br J Surg (1998) 1.48
Internal anal sphincter repair. Int J Colorectal Dis (1997) 1.47
Gender differences in the longitudinal pressure profile of the anal canal related to anatomical structure as demonstrated on three-dimensional anal endosonography. Br J Surg (2000) 1.46
Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retroviruses (1992) 1.45
Peptide-containing neurons in different regions of the submucous plexus of human sigmoid colon. Gastroenterology (1992) 1.44
Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study. Aliment Pharmacol Ther (2011) 1.43
Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells. Clin Exp Immunol (1985) 1.42
Postoperative recurrence of Crohn's disease: impact of endoscopic monitoring and treatment step-up. Colorectal Dis (2013) 1.42
Effect of age, sex and parity on anorectal function. Br J Surg (1994) 1.42
Bacillus anthracis on Gruinard Island. Nature (1981) 1.41
Low dose interferon gamma for refractory Crohn's disease. Ital J Gastroenterol Hepatol (1997) 1.41
Anterior anal sphincter repair in patients with obstetric trauma. Br J Surg (1994) 1.41
Biofeedback provides long-term benefit for patients with intractable, slow and normal transit constipation. Gut (1998) 1.39
Myopathy of internal anal sphincter with polyglucosan inclusions. J Pathol (1990) 1.39
Anal endosonography in the investigation of faecal incontinence. Br J Surg (1991) 1.37
Intestinal pseudo-obstruction with deficient smooth muscle alpha-actin. Histopathology (1992) 1.37
Morphology and phenotype of dendritic cells from peripheral blood and their productive and non-productive infection with human immunodeficiency virus type 1. Immunology (1991) 1.36
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut (2006) 1.36
Topical glyceryl trinitrate in the treatment of chronic anal fissure. Br J Surg (1996) 1.35
A single dose sub-unit vaccine protects against pneumonic plague. Vaccine (2000) 1.35
Anal endosonography and correlation with in vitro and in vivo anatomy. Br J Surg (1993) 1.35
The normal range and a simple diagram for recording whole gut transit time. Int J Colorectal Dis (1992) 1.33
Relationship between psychological state and level of activity of extrinsic gut innervation in patients with a functional gut disorder. Gut (2001) 1.32
Antigen-presenting cell types. Curr Opin Immunol (1993) 1.31
The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. FEMS Immunol Med Microbiol (1999) 1.31
Pudendal nerve damage during labour: prospective study before and after childbirth. Br J Obstet Gynaecol (1994) 1.31
Veiled (dendritic) cells in synovial fluid. Lancet (1983) 1.30
Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. Immunology (1992) 1.30
Lateral ligament division during rectopexy causes constipation but prevents recurrence: results of a prospective randomized study. Br J Surg (1991) 1.29
Effects of short term sacral nerve stimulation on anal and rectal function in patients with anal incontinence. Gut (1999) 1.28
MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials. Aliment Pharmacol Ther (2007) 1.28
Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers. Gut (1998) 1.26